修正:Theravance Biopharma第四季度营收4590万美元,低于IBES预估的5850万美元(金额已修正)

美股速递
Mar 19

修正:Theravance Biopharma Inc. (TBPH) 公布第四季度财务数据,其营收为4590万美元,显著低于IBES分析师此前预估的5850万美元。此次公布为修正后的准确金额。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10